Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up
In brief
This prospective clinical study followed patients with early knee osteoarthritis who received two standardised platelet-rich plasma (PRP) injections. Pain and function scores improved, with some loss of benefit by the end of the first year and greater gains in milder disease. No major complications occurred; the authors describe PRP as safe and effective in early osteoarthritis, while noting further studies are needed.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up Authors: Deepak Rai, Jyotsana Singh, Thimmappa Somashekharappa and Ajit Singh Link: https://doi.org/10.1051/sicotj/2021003 Year of Publication: 2021
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

